Middle East Pharmaceutical Industries Co.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA160G51UO10
SAR
104.80
-3.6 (-3.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
137.52
107.95
117.66
97.36
135.99
81.06
101.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
137.52
107.95
117.66
97.36
135.99
81.06
101.13
Raw Material Cost
48.71
47.00
45.44
38.38
50.20
36.68
39.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
26.17
32.08
30.44
26.60
26.20
24.09
27.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.56
0.84
0.73
1.11
0.95
0.90
0.73
Selling and Distribution Expenses
42.14
50.09
43.77
36.58
39.53
37.69
37.59
Other Expenses
-2.67
-3.29
-3.12
-2.77
-2.71
-2.50
-2.83
Total Expenditure (Excl Depreciation)
90.85
97.08
89.21
74.96
89.73
74.38
76.63
Operating Profit (PBDIT) excl Other Income
46.7
10.9
28.4
22.400000000000002
46.3
6.7
24.5
Other Income
-0.17
-0.20
-0.66
-0.35
1.12
-0.29
-0.34
Operating Profit (PBDIT)
51.68
15.88
32.81
26.60
52.21
10.60
27.66
Interest
0.56
0.84
0.73
1.11
0.95
0.90
0.73
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
88.81
60.95
72.21
58.98
85.79
44.38
62.09
Depreciation
5.18
5.21
5.03
4.55
4.83
4.21
3.50
Profit Before Tax
45.93
9.82
27.05
20.94
46.43
5.49
23.43
Tax
1.41
1.54
2.24
1.54
1.63
1.63
1.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.52
8.28
24.81
19.40
44.81
3.87
21.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
44.52
8.28
24.81
19.40
44.81
3.87
21.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.52
8.28
24.81
19.40
44.81
3.87
21.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
416.24
371.33
385.17
387.61
368.21
326.19
337.15
Earnings per share (EPS)
2.23
0.41
1.24
0.97
2.24
0.19
1.09
Diluted Earnings per share
2.23
0.41
1.24
0.97
2.24
0.19
1.09
Operating Profit Margin (Excl OI)
33.94%
10.07%
24.18%
23.01%
34.02%
8.25%
24.23%
Gross Profit Margin
37.17%
13.93%
27.27%
26.18%
37.7%
11.96%
26.63%
PAT Margin
32.38%
7.67%
21.09%
19.92%
32.95%
4.77%
21.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Markets Mojo
Analysis not available
Compare Quarterly Results Of Middle East Pharmaceutical Industries Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
137.52
0
137.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
137.52
0
137.52
Raw Material Cost
48.71
0
48.71
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
26.17
0
26.17
Power Cost
0
0
0.00
Manufacturing Expenses
0.56
0
0.56
Selling and Distribution Expenses
42.14
0
42.14
Other Expenses
-2.67
0.00
-2.67
Total Expenditure (Excl Depreciation)
90.85
0
90.85
Operating Profit (PBDIT) excl Other Income
46.67
0.00
46.67
Other Income
-0.17
0
-0.17
Operating Profit (PBDIT)
51.68
0
51.68
Interest
0.56
0
0.56
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
88.81
0
88.81
Depreciation
5.18
0
5.18
Profit Before Tax
45.93
0
45.93
Tax
1.41
0
1.41
Provisions and contingencies
0
0
0.00
Profit After Tax
44.52
0
44.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
44.52
0
44.52
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.52
0
44.52
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
416.24
0
416.24
Earnings per share (EPS)
2.23
0
2.23
Diluted Earnings per share
2.23
0
2.23
Operating Profit Margin (Excl OI)
33.94%
0%
0.00
33.94%
Gross Profit Margin
37.17%
0%
0.00
37.17%
PAT Margin
32.38%
0%
0.00
32.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %